Angela Vinturache, Université de Montréal

Research

Il-1 Receptor Antagonist Inflammation Interleukin-1 Myometrial Contractions Pre-Clinical Preterm Birth Tocolytics

Latest funding

A Breakthrough Solution to Effectively Prevent Preterm Birth
CIHR · 2024 · Principal investigator
$599,500

A Breakthrough Solution to Effectively Prevent Preterm Birth

Principal investigatorCIHR2024Op. Grant: NWHRI: Innovation Fund - Translational Research

Principal investigators: Chemtob, Sylvain; Vinturache, Angela E

Keywords: Il-1 Receptor Antagonist; Inflammation; Interleukin-1; Myometrial Contractions; Pre-Clinical; Preterm Birth; Tocolytics

$599,500

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2024

Subject: Prospective PhD student: Il-1 Receptor Antagonist Dear Professor Vinturache, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on il-1 receptor antagonist connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "A Breakthrough Solution to Effectively Prevent Preterm Birth" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]